Page last updated: 2024-09-03

elacridar and Brain Stem Neoplasms

elacridar has been researched along with Brain Stem Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becher, OJ; Chung, AH; Crabtree, D; Elmquist, WF; Halvorson, KG; Hu, G; Mittapalli, RK; Parrish, KE	1

Other Studies

1 other study(ies) available for elacridar and Brain Stem Neoplasms

Article	Year
ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model. Molecular cancer therapeutics, 2016, Volume: 15, Issue:5 Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Brain Stem Neoplasms; Cell Line, Tumor; Dasatinib; Disease Models, Animal; Drug Synergism; Gene Expression; Glioma; Humans; Mice; Mice, Knockout; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Tetrahydroisoquinolines; Treatment Outcome; Xenograft Model Antitumor Assays	2016

Article

Year

ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.

Molecular cancer therapeutics, 2016, Volume: 15, Issue:5

Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Brain Barrier; Brain Stem Neoplasms; Cell Line, Tumor; Dasatinib; Disease Models, Animal; Drug Synergism; Gene Expression; Glioma; Humans; Mice; Mice, Knockout; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Tetrahydroisoquinolines; Treatment Outcome; Xenograft Model Antitumor Assays

2016